Viruses, bacteria and parasites can cause deleterious diseases requiring rapid and efficient detection and therapeutic tools. Emerging infectious diseases with little known mechanisms of infection and pathogenicity represent a big challenge for research and clinics.
The discovery of host-pathogen interactions, pathogen epitopes and patient immune responses are essential in order to develop new preventive or therapeutic approaches such as vaccines and new drugs. In a similar way, epidemiological studies handle big patient cohorts for which automation and high throughput are needed. On that note, microarrays and the Innoscan’s fluorescent detection can be used at any step of the infectiology research, from pathogen detection to vaccine validation.
Using dedicated glycan arrays and the InnoScan 1100, researches are now able to define precise mechanisms of virus and bacterial infection. In a similar way, epitope mapping with high density peptide arrays scanned with the InnoScan 710-IR or the InnoScan 1100, are precious tools for understanding immune response, defining immunogenic epitopes, and for designing and validating vaccines.
